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OBJECTIVES: To develop best practices, tools, capacity and capability for an effec-
tive formulary management system for five public health care institutions in
Singapore. METHODS: A survey was conducted among formulary committee
members of the participating institutions as part of gap analysis. A cross-institu-
tion task force comprising decision makers, clinicians, pharmacists and health
technology assessment (HTA) researchers from participating institutions was
formed to recommend best practices for formulary submission, evidence review
and synthesis, pharmacoeconomic evaluation and criteria for decision making.
Endorsement fromparticipating institutions’ stakeholderswas obtained before the
implementation of this programme. RESULTS: The gap analysis highlighted three
key areas for improvement: 1) methodologies for evidence review and synthesis,
and pharmacoeconomic evaluation; 2) criteria for formulary decision making; and
3) capacity and capability building especially in pharmacoeconomics. A set of tools
that facilitate evidence review and synthesis including guidelines for pharmaco-
economic evaluation was developed with reference to published literatures and
international guidelines. Clinical need, safety, efficacy, cost-effectiveness, budget
impact and opinion from subject matter experts were deemed as important deci-
sion-making criteria. A decision-making form incorporating these criteria was cre-
ated to facilitate the consistency and transparency of the decisionmaking process.
Workshops focused on HTA were conducted to equip pharmacists supporting for-
mulary management for participating institutions the knowledge and skills to ap-
praise clinical and economic evidence. In addition, a team comprising personnel
trained in pharmacoeconomics was set up to provide support to institutions phar-
macists on the application of HTA via joint review on selected new drug
applications. CONCLUSIONS: Support from participating institutions formulary
committees and seniormanagement are keys for the successful implementation of
this programme. Moving forward, the challenge is to integrate the proposed
changes into current practice.
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OBJECTIVES: To evaluate doctors’ knowledge, attitude and practices on Malaysian
CPG 2008 along with factors predicting guidelines adherence and hypertension
control. METHODS: This was a co-relational study conducted at Hospital Pulau
Pinang, Malaysia. A total of 26 doctors were enrolled. Doctors’ knowledge and
attitude onCPG (2008)were evaluated through a valid and reliable questionnaire. In
order to evaluate doctors’ actual prescribing practices, prescriptions written by 26
enrolled doctors to 650 established hypertensive outpatients (25 prescriptions per
doctor) were noted on visit one. The noted prescriptions were classified either as
compliant or noncompliant to CPG (2008). Five hundred and twenty enrolled pa-
tients (20 patients per doctor) were followed for one more visit. Blood pressure
noted on visit 2 was related to the prescription written on visit one. SPSS 16 was
used for data analysis. RESULTS: Nineteen doctors (73.07%) had adequate knowl-
edge of CPG (2008). Doctors were highly positive towards CPG (2008) with mean
attitude score of 23.151.34 points on a 30 point scale. Statistically significant
correlation (rs0.635, p-value0.001) was observed between doctors’ knowledge
and practice scores. The majority (67.1%) patients received guidelines compliant
therapy. In multivariate analysis hypertension clinic (OR0.398, p-value0.008)
was the strong predictor of poor adherence with guidelines. On visit Two 51%
patients were at goal BP. In multivariate analysis, Angiotensin converting enzyme
inhibitors (OR2.100, p-value0.001) and guidelines adherence (OR1.745,
p-value0.022) were the strong predictors of hypertension control, while renal dis-
ease (OR0.283, p-value0.001), diabetes mellitus (OR0.598, p-value0.025) and
diabetic clinic (OR0.384, p-value0.024) were the strong predictors of poor control
of hypertension. CONCLUSIONS: An overall fair level of doctors’ knowledge, ad-
herence with guidelines and control of hypertension was observed. The gaps be-
tween what guidelines recommended and clinical practice was especially seen in
the pharmacotherapy of uncomplicated hypertension and hypertension with dia-
betes mellitus and renal disease.
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GUIDELINE IMPLEMENTATION IN LONG TERM ASTHMA MANAGEMENT: AN
AUDIT USING A MEDICATION ASSESSSMENT TOOL IN SELAYANG HOSPITAL
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OBJECTIVES: To assess the current practice for the management of long term
asthma inMalaysia and the prescribing pattern among asthmatic patients by using
medication assessment tools (MAT). The MAT was developed according to guide-
line used by the physicians in Selayang Hospital.METHODS: The development and
validation of asthma MAT had undergone a process that involved selection of
guideline on long termasthmamanagement in adults. The recommendationswere
focused on pharmacologic management. Updated version of GINA guidelines was
used as GINA guidelines is known to be used in the management of long term
asthmatic patients in Selayang Hospital. The MAT tool was then discussed and
validated together with practising pharmacist. Pilot sampling was done and data
was then collected from patient medical record in Selayang Hospital. These data
were then assessed using Microsoft Access and Microsoft Excel. RESULTS: The
result showed that level of adherence towards guidelines used was 86.3% for 73
asthmatic patients that were selected. If magnification was made, however, the
reduction of current medication dose had not been made after the symptoms of
asthma have been controlled and only 39.4% had their dose reduced according to
the guideline. CONCLUSIONS: The adherence of guidelines seem to be high, how-
ever, improvement needs to bemade in reducing the dose once patients’ asthmatic
symptoms have been resolved.
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Clinical guidelines recommend patients with Diffuse Large B-Cell Lymphoma (DL-
BCL) receive anthracycline-based chemotherapy (ABC) treatment. During the
1990s, however, about one- third of elderly DLBCL patients did not receive chemo-
therapy, potentially due to intolerance of toxicities associated with ABC. With the
addition of rituxmab in the late 1990s, it appears that physicians choose to use
non-guideline rituximab plus non-ABC chemotherapy for patients with low toxic-
ity tolerance. OBJECTIVES: This study assesses the diffusion of the use of non-
guideline chemotherapy treatment for elderly DLBCL patients and examines the
regional variation in diffusion.METHODS:A retrospective cohort consisting of 5839
Medicare beneficiaries diagnosed in 2000-2006 with primary DLBCL at age 66 or
older treated with any chemotherapy was selected from the 2007 Surveillance,
Epidemiology and End Results (SEER)-Medicare linked database. Patients were ex-
cluded if physician information was not available (N55). Patient chemotherapy
was categorized usingMedicare claimswithin fivemonths of diagnosis. Physicians
(N3,072) were included if they prescribed any chemotherapy to patients during
the initial treatment period. Descriptive analyses were used to characterize varia-
tion in chemotherapy treatment across the SEER registry regions. RESULTS: Phy-
sicians prescribed ABC chemotherapy to on average 81.2% of received chemother-
apy patients. A totla of 19.8% of physicians, however, prescribed rituximab plus
non-ABC chemotherapy to at least one patient. The percentage of physicians
whom used rituximab plus non-ABC chemotherapy increased from 1.4% in 2000 to
16.1% in 2006. Louisiana, Connecticut, and Seattle were the top three SEER regions
where over 23% of the physicians prescribed this alternative chemotherapy. In
Hawaii, New Mexico, and Iowa SEER regions less that 14% of physician used this
alternative chemotherapy. CONCLUSIONS: The percentage of physicians having
adopted rituximab plus non-ABC chemotherapy as the alternative treatment in-
creased over the years. Physicians’ adoption of non-guideline treatment varies
across regions.
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OBJECTIVES: HCC has a substantial disease burden worldwide, especially in AP.
The global HCC BRIDGE study is the first global, large-scale, observational study to
document real-world treatment pattern and outcomes of HCC patients from diag-
nosis to death. METHODS: This longitudinal cohort study includes HCC patients
newly diagnosed between January 2005 and June 2011 and treated atmajormedical
centers, with data collected retrospectively and prospectively as recorded in pa-
tient charts. RESULTS: In the first interim analysis (July 2011), 8909 patients (mean
age, 54 years; 83% male) were enrolled in AP (China, n6295; Taiwan, n1183;
Korea, n1136; Japan, n295). The predominant risk factorwasHBV inChina (80%),
Taiwan (67%), and Korea (77%), and HCV in Japan (69%). The predominant BCLC
stage at diagnosiswas stage C in China (56%) andKorea (51%) and stageA in Taiwan
(55%) and Japan (47%). Variations were noted between China, Taiwan, Korea, and
Japan in first-recorded treatment with resection/transplant (31%, 51%, 23%, 14%),
TACE (53%, 27%, 55%, 24%), other locoregional therapy (9%, 18%, 8%, 52%), and
systemic therapy (2%, 3%, 11%, 13%). There also were variations in treatment ever
used with resection/transplant (34%, 53%, 29%, 16%), TACE (61%, 37%, 65%, 28%),
other locoregional therapy (17%, 30%, 17%, 64%), and systemic therapy (5%, 9%,
30%, 19%). Recorded treatment by line of therapy, BCLC and mUICC stage, and
country will be presented from the second interim analysis, which will include
17,000 patients. Actual practice and expected practice according to guidelineswill
be evaluated, including how access issues may affect treatment availability.
CONCLUSIONS: The global HCC BRIDGE study, which is the largest study of its kind
(in approximately 19,000 patients), provides valuable insights into global HCC dis-
ease characteristics and patient management. Although AP has the highest HCC
burden, practice approaches differ across the region.
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OBJECTIVES: During hajj season, more than 2 million hajj pilgrims would be occu-
pying the holy land Makkah with area of 164,000 km2. On the observation many of
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themhad upper respiratory infection due to congested and dusty environment. On
previous observation may of hajj pilgrims were given antibiotic for their URTIs.
Most of antibiotics prescribed to pilgrimswere based onprescribers judgments.The
study aims to determine the prevalence severity and the pattern of antibiotic
usage. METHODS: This cross sectional study was conducted from December 2007
to January 2008. Validated self administered questionnaire forms were distributed
to about 3,000 Malaysian Hajj Pilgrims in Makkah of Saudi Arabia. The severity of
URTIs was based on the patient’s perception and the number of symptoms.
RESULTS: Majority, 87.1% of 2194 pilgrims reported had URTIs, 12.4%, (41.6%) and
(46.0%) of pilgrims were categorised severe, moderate, and mild respectively. An-
tibiotics were prescribed to 58.8% pilgrims, the pattern of antibiotic used was as-
sociated with severity (p 0.001) and the number of symptoms(p 0.001)and 55.1%
of them had fever. Many of them(68.8%), take one course of antibiotic, while 28.5 %
and 8.0% received two and three causes. CONCLUSIONS: A high prevalence of
URTIs was found among Malaysian Hajj Pilgrims. Most of the pilgrims with mod-
erate to severe and had fever received antibiotics. About one third of them, how-
ever,were not get benefit fromfirst course of antibiotics. Proper antibiotic guideline
that supported by microbiological studies are proposed to justify the use of antibi-
otics for hajj pilgrims.
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OBJECTIVES: To evaluate the use of sedatives in critically ill adult patients with
endotracheal tube (ETT) and mechanical ventilator (MV) in a hospital in Taiwan.
METHODS:We conducted the study retrospectively by reviewing medical records.
All patients with ICD-9, 96.71, 96.72, 96.04, fromOct 2008 to Feb 2009were included.
Patients were excluded if they were pediatric patients, without complete records,
using MV after discharged, in regular wards, or using MV less than 24 hours. The
primary end point is the duration of mechanical ventilation. The secondary end
points were length of ICU stay, hospital stay and events of tracheostomy, reintu-
bation, self-extubation. Chi square and t-test were performed for dichotomous and
continuous variables respectively. SPSS (Version 13.0) was used. The data were log
transformed to address the non-normal distribution. RESULTS: We collected 50
events of insertion of endotracheal tube with mechanical ventilator (ETTMV) in
using sedatives group and 163 in not using group. The duration of mechanical
ventilation was not significantly difference between two groups. (p 0.582) The
using sedatives group had longer ICU (p 0.04) and hospital length of stay (p
0.001). There were much more patients were physically restricted in the using
sedatives group (84% vs. 56%). The usages of sedatives were 50% ofmidazolam and
54% of propofol. The mean treatment duration among patients receiving midazo-
lam was 4.6 days and 2.2 days among patients with propofol. This longer duration
of length of stayswere possibly related to the usage ofmidazolamand the prescrib-
ing habits of physicians. CONCLUSIONS: We found the physician preference by
using physical restriction as first line and sedatives as second line did not benefit
the critically ill patients.Wewill implement a sedation guideline to tailor the needs
of our facility for optimal the patient care.
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OBJECTIVES: To investigate the real-world diagnosis and treatment patterns of
iron deficiency anemia (IDA) in China. METHODS: Literature review, Key Opinion
Leaders survey, and patient case reviewwere conducted. The reviewwas based on
China Academic Journals Full-text Database (2006-2010). A total of 163 publications
were targeted by searching in terms of IDA diagnosis and treatment. A total of 44
senior physicians specialized in nephrology, hematology and obstetrics/gynecol-
ogy were selected from tertiary hospitals in Beijing, Shanghai, Guangzhou, She-
nyang and Chengdu, who were requested to complete a questionnaire in two
weeks. The structured questionnaire included IDA awareness, diagnosis, treat-
ment and related drivers and restrictions. Information on Lab tests and treatments
were collected from 91 patient cases. Descriptive analysis was performed. The
results of KOL survey and patient case review were consistent, indicating the va-
lidity of the results. RESULTS: IDA wasmost likely found in patients in nephrology
and obstetrics/gynecology, and in patients with chronic kidney disease on hemo-
dialysis. Seventy-five percent of nephrologists, 58% of hematologists, and 25% of
obstetricians/gynecologists reported the existence of hospital-wide guidelines for
IDA diagnosis and treatment, respectively. Lab tests and cut-off for IDA diagnosis
varied across different specialties and different physicians in the same specialty.
Intravenous (IV) ironwasmore effective and caused less side effects than oral iron.
IV iron sucrose increased hemoglobin level faster and greater than intramuscular
iron dextran. Nephrologists usually prescribed IV iron as the first line, while hema-
tologists and obstetricians/gynecologists preferred oral iron. Price was not the
most influential driver for using IV iron. Fifty-seven percent of KOLs, however,
reported the restrictions of IV iron use due to cost.CONCLUSIONS:Guideline-based
diagnosis and treatment for IDA needs to be strengthened in China. Real-world
prescription of IV iron for IDA varied across specialties andmay be restricted due to
cost despite its better effectiveness.
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OBJECTIVES: To develop national medicine brand substitution guidelines and as-
sessment of its adoptability among community pharmacist and general practitio-
ners in Malaysia.METHODS: A cross sectional postal survey was conducted with a
sample of 100 community pharmacists and 100 general practitioners selected sys-
tematically in the state of Penang, Malaysia. A pre validated questionnaire was
used for data collection. Frequencies and percentages were used to elaborate the
data. SPSS v. 16 was used for data analysis. RESULTS: From a total of 200 question-
naires mailed, the response rate was 16% (n16) for general practitioners and 36%
(n36) for community pharmacist. Majority of the respondents (n53, 85.4%) dis-
agreed that generic medicines lead to more side effect as compared to innovator
brands. However, 59.6% (n37) reported that Innovator brands are more effective
than genericmedicines. Moreover, (n33, 53.2%) agreed that genericsmedicine are
not bioequivalent to the innovator brands. Majority (n40, 64.5%) stated that ge-
nericmedicines should be available in samedosage formand strength as innovator
brand medicines. Almost all respondents (n52, 83.8%) demanded that dispensed
medicines should be labelled with the generic (INN) name of the medicine with or
without the brand name. While comparing with general physicians (n13, 81.3%),
community pharmacists (n33, 91.7%) were in high favor that a written national
generic brand substitution guideline is needed in Malaysia. In addition, all of the
respondents strongly agreed to the statement that thorough counselling should be
provided to the patients if their medicine is changed from innovator brand to
generic in order to avoid confusion. CONCLUSIONS: Majority of general practitio-
ners and community pharmacists in Penang agreed to the contents of the draft
national medicine brand substitution guideline. This is a good indicator that the
contents can actually be the foundation of an actual national medicine brand sub-
stitution guideline.
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USAGE OF SELF-MONITORING OF BLOOD GLUCOSE (SMBG) BY DIABETES
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OBJECTIVES: SMBG is one of the core components of diabetes therapy. It supports
a safe and effective drug therapy and provides additional feedback on howdiet and
lifestyle impact blood glucose levels. In 2011 a Chinese guideline on SMBG was
published. SMBG, in contrast to most diabetes drugs, is not reimbursed. This study
aims to assess the level of SMBG usage in patients on different diabetes therapies.
METHODS: 1st half year 2011 data (10,418 cases) from the CSD PDS Diabetes survey
were used for this explorative analysis. PDS Diabetes is a syndicated research with
a fixed representative panel of endocrinologists and cardiologists from 13 large
Chinese cities. Patient cases are documented in a standardized format. SMBGusage
was analyzed by therapy-subgroups: oral diabetes therapy only (OAD 54%), basal
supported oral therapy (BOT 18%), conventional insulin therapy (CT 20%), intensive
insulin therapy (IIT 6%) and OTHERS (2% - not reported). RESULTS: Ninety-five
percent were patients with type 2 diabetes. A total of 5288 patients (50.8%) had a
meter for home-testing. Shares of testers by therapies (OAD / BOT / CT / IIT) were
34.7%, 60.1%, 53.4% and 48.4%. Average weekly test frequencies were 2.8, 3.3, 3.0
and 4.0 respectively. In the IIT group 1% tested at least 3 times a day. HbA1c levels
were by 0.2%, 0.5%, 0.4% and 1.2% lower in SMBG users. CONCLUSIONS:High share
of patients don’t have a meter to perform SMBG at home. For testers with BOT, CT
and IIT test-frequencies remained clearly below the Chinese guideline recom-
mending 10, 10 and 21 test per week respectively. For IIT (SMBG is needed to
support insulin dose adjustments) only 1% tested at the guideline-recommende
frequency. In IIT patients differences in HbA1 were largest between testers and
non-testers. Further research is needed to clarify if e. g. education or reimburse-
ment could potentially resolve these shortfalls.
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UTILIZATION OF FPG, HBA1C AND SELF-MONITORING OF BLOOD GLUCOSE
(SMBG) IN COMMUNITY HEALTH CENTERS IN THE SHANGHAI AREA
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OBJECTIVES:Utilization of fasting plasma glucose (FPG), HbA1c and SMBG are con-
sidered core components of diabetes therapy. They support a safe and effective
drug therapy and they provide feedback on the quality of glycemic control. In
2011 a Chinese guideline on SMBG was published. SMBG, in contrast to most dia-
betes drugs, is not reimbursed in China. This study aims to assess the level of SMBG
usage with patients on different diabetes therapies in community health centers
(primary care). METHODS: In 2012 a survey was conducted in community health
centers in 6 districts of Shanghai. 935 random diabetes cases were documented in
a standardized format. Subsequent explorative analysis were performed. SMBG
usage was analyzed by therapy-subgroups: oral diabetes therapy only (OAD 84%),
any therapy involving insulin (INSULIN 14%) and OTHERS (2%). RESULTS: 99%were
patients with type 2 diabetes. FPG levels were available for 86% and 89% in OAD/
INSULIN respectively, HbA1c levelswere available for 32.0% and 19.4% respectively.
For 124 patients (13.3%) SMBG usage was reported, for 111 of them actual test
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